Ms. Samel is a PharmD candidate, Northeastern University, Boston, Massachusetts.
Lauren Stummer, PharmD, BCPP
Dr. Stummer is Clinical Operational Pharmacist and Director, PGY2 Psychiatry Pharmacy Residency Program, McLean Hospital, Belmont, Massachusetts.
Andrew Karas, PharmD, BCPP
Dr. Karas is Clinical Operational Pharmacist, McLean Hospital, Belmont, Massachusetts.
Alexis Freedberg, MD
Dr. Freedberg is Part-Time Instructor in Psychiatry, Harvard Medical School, Boston, Massachusetts, and Psychiatrist-in-Charge, Cognitive Neuropsychiatry Unit, McLean Hospital, Belmont, Massachusetts
Disclosures
The authors report no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.
CASE CONTINUED
After reviewing Ms. A’s medical history, the treatment team initiates chlorpromazine, 25 mg 3 times a day, for intractable hiccups, and increases the dosage to 50 mg 3 times a day after 3 days. Chlorpromazine is FDA-approved for treating bipolar mania, and also for treating intractable hiccups. Shortly thereafter, Ms. A’s hiccups subside, she sleeps for longer periods, and her manic symptoms resolve.
